| 发明名称 |
PULMONÄRE VERABREICHUNG DES LÖSLICHEN KOMPLEMENT-RECEPTORS TYP 1 sCR1 |
| 摘要 |
A method is disclosed for treating diseases or disorders involving complement by pulmonary administration of complement inhibitory proteins such as soluble complement receptor type 1 (sCR1). The present invention relates to the direct treatment of certain complement related disorders by administering complement inhibitory proteins via the pulmonary route, in particular, by direct delivery to the lungs by aerosolization of a complement inhibitory protein and subsequent inhalation. |
| 申请公布号 |
DE69431290(D1) |
申请公布日期 |
2002.10.10 |
| 申请号 |
DE1994631290 |
申请日期 |
1994.02.08 |
| 申请人 |
AVANT IMMUNOTHERAPEUTICS, INC.;THE REGENTS OF THE UNIVERSITY OF MINNESOTA, MINNEAPOLIS |
发明人 |
LEVIN, JAMES L.;REGAL, JEAN F.;TOTH, CAROL A. |
| 分类号 |
C12N15/09;A61K9/00;A61K9/12;A61K9/72;A61K38/00;A61K38/17;A61K38/43;A61P9/00;A61P9/10;A61P11/00;A61P11/08;A61P25/00;A61P29/00;A61P31/00;A61P31/04;A61P37/00;A61P37/06;C07K14/705;C12N5/10;C12P21/02;C12R1/91;(IPC1-7):A61K38/55 |
主分类号 |
C12N15/09 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
